Health Catalyst, Inc. (NASDAQ:HCAT) CFO Sells $163,063.68 in Stock

Health Catalyst, Inc. (NASDAQ:HCAT) CFO Jason Alger sold 19,599 shares of the stock in a transaction dated Friday, December 6th. The shares were sold at an average price of $8.32, for a total value of $163,063.68. Following the completion of the sale, the chief financial officer now owns 86,712 shares of the company’s stock, valued at approximately $721,443.84. This trade represents a 18.44 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Health Catalyst Stock Up 0.4 %

Shares of Health Catalyst stock traded up $0.03 during trading on Tuesday, reaching $8.37. The company had a trading volume of 393,567 shares, compared to its average volume of 564,733. The company has a market cap of $509.30 million, a price-to-earnings ratio of -6.20 and a beta of 1.31. Health Catalyst, Inc. has a fifty-two week low of $5.42 and a fifty-two week high of $11.41. The firm’s fifty day moving average is $8.13 and its 200-day moving average is $7.39. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.41 and a current ratio of 1.41.

Health Catalyst (NASDAQ:HCAT) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.10 by ($0.03). The firm had revenue of $76.40 million for the quarter, compared to analyst estimates of $76.27 million. Health Catalyst had a negative net margin of 26.20% and a negative return on equity of 7.51%. The company’s quarterly revenue was up 3.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.22) EPS. On average, analysts anticipate that Health Catalyst, Inc. will post -0.33 EPS for the current year.

Analysts Set New Price Targets

HCAT has been the subject of several recent research reports. JPMorgan Chase & Co. increased their price objective on shares of Health Catalyst from $10.00 to $13.00 and gave the company an “overweight” rating in a research report on Wednesday, September 4th. Stephens upped their target price on shares of Health Catalyst from $7.00 to $9.00 and gave the company an “equal weight” rating in a research note on Thursday, November 14th. Piper Sandler reaffirmed an “overweight” rating and set a $12.00 price target (up previously from $11.00) on shares of Health Catalyst in a research note on Tuesday, November 26th. Cantor Fitzgerald reissued an “overweight” rating and issued a $16.00 price objective on shares of Health Catalyst in a research report on Friday, October 4th. Finally, Royal Bank of Canada raised their target price on Health Catalyst from $8.00 to $9.00 and gave the company a “sector perform” rating in a research note on Thursday, November 7th. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $11.79.

Hedge Funds Weigh In On Health Catalyst

Large investors have recently added to or reduced their stakes in the company. Primecap Management Co. CA raised its holdings in shares of Health Catalyst by 14.7% during the second quarter. Primecap Management Co. CA now owns 2,379,462 shares of the company’s stock worth $15,205,000 after purchasing an additional 305,079 shares during the period. Janney Montgomery Scott LLC bought a new stake in shares of Health Catalyst during the 3rd quarter valued at about $897,000. Fred Alger Management LLC acquired a new stake in Health Catalyst during the third quarter worth about $6,858,000. Essex Investment Management Co. LLC bought a new position in Health Catalyst in the third quarter worth about $2,012,000. Finally, Millrace Asset Group Inc. acquired a new position in Health Catalyst in the third quarter valued at approximately $1,568,000. 85.00% of the stock is currently owned by institutional investors.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.